Withings Pulse Wave Velocity and Blood Pressure Study

NCT ID: NCT03099954

Last Updated: 2018-03-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-01-19

Study Completion Date

2017-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Measure pulse wave velocity stability in relation to time of day, day of the week, physical activity, sleep quality, stress levels and blood pressure.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study population will be an estimated 300 healthy adult subjects from the United States. This population will be approximately 150 men and 150 women. In order to obtain a relatively diverse age range of users (with varying levels of arterial stiffness), we hope to enroll participants across three age ranges entered in the Withings application by the user: 18-40 years, 41-60 years, and \> 60 years. These spots will be filled by those that satisfy the inclusion/exclusion criteria on a first come, first served basis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Elevated Blood Pressure Hypertension Mental Stress Sleep Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* User of a (1) Withings blood pressure cuff (2) Withings activity tracker and (3) Withings Body Cardio scale
* User has measured their blood pressure at least once per week for the majority of weeks over the last three months.

Exclusion Criteria

* Aortic artery disease
* Peripheral vascular disease
* Atrial fibrillation
* Weight \> 396 lbs.
* Pregnant women
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Withings

INDUSTRY

Sponsor Role collaborator

Scripps Translational Science Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Brian D Modena, MD

Role: PRINCIPAL_INVESTIGATOR

Scripps Translational Science Institute

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Scripps Translational Science Institute

La Jolla, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB-16-6856

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Vital Signs Blood Pressure Trial
NCT06272318 NOT_YET_RECRUITING
Behavioral Study to Control Blood Pressure
NCT01035554 COMPLETED PHASE2/PHASE3